Evaluation of the Cancer Tracking System (CATSystem) - Trial NCT06286462
Access comprehensive clinical trial information for NCT06286462 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Kansas Medical Center and is currently Recruiting. The study focuses on Cervical Cancer. Target enrollment is 6600 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Kansas Medical Center
Timeline & Enrollment
N/A
Feb 05, 2024
Jan 31, 2028
Primary Outcome
Guideline adherent treatment for a positive screen,Cost-effectiveness of the CATSystem Intervention on screening and treatment outcomes
Summary
Cervical cancer contributes to significant preventable mortality in Kenya where less than 20%
 of women are screened. The Cancer Tracking System (CATSystem) is a web-based, algorithm
 generated tool to promote guideline adherent cervical cancer screening and retention through
 treatment. The goal of this project is to rigorously evaluate the efficacy, implementation,
 and cost-effectiveness of the CATSystem to improve rates of screening, treatment, referral,
 and follow-up care in a matched, cluster randomized controlled trial in 10 Kenyan government
 hospitals (5 intervention, 5 standard of care).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06286462
Non-Device Trial